{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:04:52Z","timestamp":1789625092505,"version":"build-2803163510"},"reference-count":22,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30\u2010CA008748"],"award-info":[{"award-number":["P30\u2010CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"DOI":"10.1111\/bju.70433","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:55:32Z","timestamp":1789624532000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is Gleason pattern 3 cancer? Molecular features do not distinguish pattern 3 from benign tissue"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0779-0984","authenticated-orcid":false,"given":"Riccardo","family":"Leni","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center  New York NY USA"},{"name":"Division of Experimental Oncology, Department of Urology IRCCS San Raffaele Scientific Institute  Milan Italy"},{"name":"Department of Urology Treviglio\u2010Caravaggio Hospital  Treviglio Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Eggener","sequence":"additional","affiliation":[{"name":"Section of Urology, Department of Surgery University of Chicago  Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Cooperberg","sequence":"additional","affiliation":[{"name":"Department of Urology University of California at San Francisco  San Francisco CA USA"},{"name":"Department of Epidemiology and Biostatistics University of California at San Francisco  San Francisco CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7461-7079","authenticated-orcid":false,"given":"Simpa S.","family":"Salami","sequence":"additional","affiliation":[{"name":"Department of Urology University of Michigan  Ann Arbor MI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1912-042X","authenticated-orcid":false,"given":"Adam B.","family":"Weiner","sequence":"additional","affiliation":[{"name":"Department of Urology Cedars\u2010Sinai Medical Center  Los Angeles CA USA"},{"name":"Department of Urology, David Geffen School of Medicine University of California\u2010Los Angeles  Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7947-7003","authenticated-orcid":false,"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pathology, Molecular and Cell\u2010Based Medicine Icahn School of Medicine at Mount Sinai  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Al\u2010Sattar","sequence":"additional","affiliation":[{"name":"School of Medicine and Biomedical Sciences University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2968-7155","authenticated-orcid":false,"given":"Alastair D.","family":"Lamb","sequence":"additional","affiliation":[{"name":"Department of Urology Guys and St Thomas' Hospital NHS Foundation Trust  London UK"},{"name":"Barts Cancer Institute Queen Mary University of London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1525-6503","authenticated-orcid":false,"given":"Andrew J.","family":"Vickers","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.22.00123","article-title":"Low\u2010grade prostate cancer: time to stop calling it cancer","volume":"40","author":"Eggener SE","year":"2022","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/PAS.0b013e3182556dcd","article-title":"Do adenocarcinomas of the prostate with Gleason score (GS) \u22646 have the potential to metastasize to lymph nodes?","volume":"36","author":"Ross HM","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1172\/JCI70354","article-title":"Tracking the clonal origin of lethal prostate cancer","volume":"123","author":"Haffner MC","year":"2013","journal-title":"J Clin Invest"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.eururo.2022.10.001","article-title":"Removing the designation of cancer from grade group 1 disease will do more good than harm","volume":"83","author":"Vickers AJ","year":"2023","journal-title":"Eur Urol"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.eururo.2022.09.015","article-title":"Prostate adenocarcinoma grade group 1: rationale for retaining a cancer label in the 2022 World Health Organization classification","volume":"83","author":"Netto GJ","year":"2023","journal-title":"Eur Urol"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41586-022-05023-2","article-title":"Spatially resolved clonal copy number alterations in benign and malignant tissue","volume":"608","author":"Erickson A","year":"2022","journal-title":"Nature"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.eururo.2013.05.029","article-title":"The mutational landscape of prostate cancer","volume":"64","author":"Barbieri CE","year":"2013","journal-title":"Eur Urol"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamaoncol.2026.1391","article-title":"Prostate cancer mortality after relabeling low\u2010grade prostate cancer as precancerous","volume":"12","author":"Vickers AJ","year":"2026","journal-title":"JAMA Oncol"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01863-2","article-title":"Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures","volume":"22","author":"Figiel S","year":"2023","journal-title":"Mol Cancer"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1593\/neo.06427","article-title":"TMPRSS2\u2010ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions","volume":"8","author":"Cerveira N","year":"2006","journal-title":"Neoplasia"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/modpathol.2009.69","article-title":"Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression","volume":"22","author":"Han B","year":"2009","journal-title":"Mod Pathol"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","DOI":"10.1177\/1179554920947322","article-title":"The role of AMACR, CD10, TMPRSS2\u2010ERG, and p27 protein expression among different Gleason grades of prostatic adenocarcinoma on needle biopsy","volume":"14","author":"G\u00fclhan \u00d6","year":"2020","journal-title":"Clin Med Insights Oncol"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"511.e1","DOI":"10.1016\/j.urology.2013.11.005","article-title":"Cancer\u2010associated changes in the expression of TMPRSS2\u2010ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimens","volume":"83","author":"Vaananen RM","year":"2014","journal-title":"Urology"},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1158\/1078-0432.CCR-07-5194","article-title":"Characterization of TMPRSS2\u2010ERG fusion high\u2010grade prostatic intraepithelial neoplasia and potential clinical implications","volume":"14","author":"Mosquera JM","year":"2008","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_16_1","article-title":"Determination of ERG(+), EZH2, NKX3.1, and SPINK\u20101 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer","volume":"6","author":"Segura\u2010Moreno YY","year":"2023","journal-title":"Cancer Rep (Hoboken)"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAI.0000000000000732","article-title":"PTEN loss in a prostate cancer cohort from Jordan","volume":"28","author":"Al Bashir S","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"e_1_2_6_18_1","first-page":"6834","article-title":"Implication of miRNA\u2010153 on PTEN expression in prostatic adenocarcinoma","volume":"25","author":"Aboushousha T","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000019778","article-title":"p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer","volume":"34","author":"Schlechte H","year":"1998","journal-title":"Eur Urol"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1464-410X.1996.85721.x","article-title":"Accumulation of p53 and expression of CD44 in human prostatic cancer and benign prostatic hyperplasia: an immunohistochemical study","volume":"77","author":"Zhang XH","year":"1996","journal-title":"Br J Urol"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.humpath.2004.06.015","article-title":"Utility of immunohistochemistry for alpha\u2010methylacyl\u2010CoA racemase in distinguishing atrophic prostate cancer from benign atrophy","volume":"35","author":"Farinola MA","year":"2004","journal-title":"Hum Pathol"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12253-016-0119-9","article-title":"SPINK1 overexpression in localized prostate cancer: a rare event inversely associated with ERG expression and exclusive of homozygous PTEN deletion","volume":"23","author":"Huang KC","year":"2017","journal-title":"Pathol Oncol Res"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1158\/1940-6207.CAPR-22-0485","article-title":"Progressive spreading of DNA methylation in the GSTP1 promoter CpG Island across transitions from precursors to invasive prostate cancer","volume":"16","author":"Gupta H","year":"2023","journal-title":"Cancer Prev Res (Phila)"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.70433","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bju.70433","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.70433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:55:35Z","timestamp":1789624535000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.70433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":22,"alternative-id":["10.1111\/bju.70433"],"URL":"https:\/\/doi.org\/10.1111\/bju.70433","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"2026-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"bju.70433"}}